DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: News

April 23, 2024
tovorafenib FDA Approval for LGG

(Courtesy of ASCO FDA Alerts) tovorafenib FDA Approval for LGG On April 23, 2024, the Food and Drug Administration granted accelerated approval to tovorafenib (Ojemda, Day One Biopharmaceuticals, Inc.) for patients 6 months of age and older with relapsed or refractory pediatric low-grade glioma (LGG) harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. […]

Read More
February 10, 2023
New Device Detects Brain Tumors Early, From Urine

Membrane proteins in urine can indicate a brain tumor early, according to researchers at Nagoya University in Japan. The could avoid the need for invasive tests and increase the likelihood of tumors being detected early enough for surgery.

Read More
January 27, 2023
Sonodynamic Therapy Clinical Trial

Read about this NEW Clinical Trial and review the eligibility guidelines! "The Ivy Brain Tumor Center at Barrow Neurological Institute is conducting a Phase 1/2 study of sonodynamic therapy (SDT) in patients with recurrent glioblastoma (rGBM).

Read More
January 20, 2023
New cell therapy, cancer killing vaccine

Scientists at Brigham and Women’s Hospital are harnessing a new way to turn cancer cells into potent, anti-cancer agents. Khalid Shah and his team have developed a new cancer-killing vaccine that can be used to treat existing tumors and prevent recurrences.

Read More
December 9, 2022
20 Year Celebration Video

The last 20 years has been hard yet exhilarating! We are so proud of how far we've come in providing Outreach, Education, & Support for those affected by brain cancer/brain tumors.

Read More
December 5, 2022
PROSPECT Clinical Trial

The PROSPECT study is a clinical trial to evaluate an investigational oral medicine for primary CNS lymphoma (PCNSL). About 112 participants will be enrolled in the study in the US.

Read More
November 17, 2022
End Brain Cancer Mobile App Is Here!

To advance our mission of education and advocacy, we have developed a mobile app where you can find information and interact with the Brain Tumor Community. Download the app today.

Read More
October 27, 2022
20 Years of Improving Patient Access!

Meet the Mission Team behind our Programs that deliver our Mission and Advocacy efforts!

Read More
October 13, 2022
Making a Difference in Healthcare

Dellann Elliott Mydland, President & Board Chair, End Brain Cancer Initiative (EBCI), is a dynamic competitor due to her experience taking down brain tumors, brain cancer, and metastasized disease to the brain. Read her new article in The Corporate Magazine.

Read More
October 7, 2022
Patient Webinar in Recognition of Breast Cancer Awareness Month

Dr. Andrew Brenner discusses a new targeted radiation therapy for metastases in breast and lung cancer in this patient-focused webinar.

Read More
October 6, 2022
Virtual Caregiver Event

Online virtual event for family caregivers featuring a social worker, who works with patients, caregivers & their families around a GBM/Brain Tumor diagnosis.

Read More
September 21, 2022
Prescription Drug User Fee Act

Show your support for the re-authorization of the PDUFA act. Send a petition for Senator Murray who leads the appropriations committee.

Read More
1 2 3

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram